Cross-institution positioning
Jul 28, 2026Reduction leaning. 1 reducing, 3 exited across 4 comparable institutions.
Source: Schedule 13 researcheHealth, Inc.
Latest stored close $0.71 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 1 reducing, 3 exited across 4 comparable institutions.
Source: Schedule 13 research0 increased/new, 2 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 4 sales by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; 1 capital-related filing/event (1 equity-related, 0 debt-related); Latest classified evidence: Employee-plan securities registration. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue -44.8% YoY; Net income -35.6% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 0% through its reported 52-week range; -77.3% over one year.
Source: Stored historical price seriesFiled Jul 28, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | SOISTMAN FRANCIS S JR | SOpen-market or private sale | Common Stock | 20.3K | $0.69 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | SOISTMAN FRANCIS S JR | SOpen-market or private sale | Common Stock | 20.3K | $0.70 | Direct | Oct 2, 2026 |
| Sep 10, 2026 | Dolan John Joseph | FTax/price withholding or payment | Common Stock | 5.9K | $0.92 | Direct | Sep 11, 2026 |
| Sep 10, 2026 | Barbeau Michelle Marie | FTax/price withholding or payment | Common Stock | 4.3K | $0.92 | Direct | Sep 11, 2026 |
| Sep 1, 2026 | Galimi Gavin G. | AGrant, award, or other acquisition | Common Stock | 60.0K | $0.00 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Dolan John Joseph | AGrant, award, or other acquisition | Common Stock | 70.0K | $0.00 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Barbeau Michelle Marie | AGrant, award, or other acquisition | Common Stock | 70.0K | $0.00 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | SOISTMAN FRANCIS S JR | SOpen-market or private sale | Common Stock | 37.3K | $1.05 | Direct | Sep 2, 2026 |
| Aug 31, 2026 | SOISTMAN FRANCIS S JR | SOpen-market or private sale | Common Stock | 37.3K | $1.14 | Direct | Sep 2, 2026 |
| Aug 4, 2026 | DUKE DERRICK A | FTax/price withholding or payment | Common Stock | 24.4K | $1.42 | Direct | Aug 5, 2026 |
| Jul 10, 2026 | Barbeau Michelle Marie | FTax/price withholding or payment | Common Stock | 323 | $1.62 | Direct | Jul 14, 2026 |
| Jul 10, 2026 | Galimi Gavin G. | FTax/price withholding or payment | Common Stock | 841 | $1.62 | Direct | Jul 14, 2026 |
| Jul 10, 2026 | Dolan John Joseph | FTax/price withholding or payment | Common Stock | 465 | $1.62 | Direct | Jul 14, 2026 |
| Apr 24, 2026 | Barbeau Michelle Marie | FTax/price withholding or payment | Common Stock | 3.6K | $1.89 | Direct | Apr 28, 2026 |
| Apr 24, 2026 | Galimi Gavin G. | FTax/price withholding or payment | Common Stock | 3.6K | $1.89 | Direct | Apr 28, 2026 |
| Apr 24, 2026 | Dolan John Joseph | FTax/price withholding or payment | Common Stock | 4.2K | $1.89 | Direct | Apr 28, 2026 |
| Apr 10, 2026 | Barbeau Michelle Marie | FTax/price withholding or payment | Common Stock | 323 | $1.32 | Direct | Apr 14, 2026 |
| Apr 10, 2026 | Galimi Gavin G. | FTax/price withholding or payment | Common Stock | 7.5K | $1.32 | Direct | Apr 14, 2026 |
| Apr 10, 2026 | Dolan John Joseph | FTax/price withholding or payment | Common Stock | 2.8K | $1.32 | Direct | Apr 14, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 5, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Aug 4, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jun 25, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| May 6, 2026 | 8-K | 2.02, 5.02, 9.01 | Results of operations / financial condition; Director or executive change; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $33.6M | -44.8% |
| Ended Jun 30, 2025 | $60.8M | — |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 28, 2026 filed · 28d Schedule 13G amendment | Reported reduction | 601.5K -1.3M | 12.00% +5.80 pts | $1.49 | $1.36 | $0.71 |
| Vanguard Group CIK0000102909 | Sep 30, 2025 observed Oct 30, 2025 filed · 30d Schedule 13G amendment | Exit below reporting threshold | 1.5M +5.0K | 4.99% -0.02 pts | $4.31 | $5.06 | $0.71 |
| Goldman Sachs Group CIK0000886982 | Jun 30, 2025 observed Aug 14, 2025 filed · 45d Schedule 13G amendment | Exit below reporting threshold | 767 -925 | 2.50% -3.20 pts | $4.35 | $3.43 | $0.71 |
Compare EHTH with other securities showing similar institutional activity or recent accumulation across several tracked institutions.